Invivyd, Inc.
General ticker "IVVD" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $179.2M (TTM average)
Invivyd, Inc. follows the US Stock Market performance with the rate: 6.7%.
Estimated limits based on current volatility of 3.6%: low 0.76$, high 0.81$
Factors to consider:
- Total employees count: 95 (+10.5%) as of 2023
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Inability to commercialize, Inability to achieve profitability, Regulatory and compliance, Cybersecurity threats, Labor/talent shortage/retention
- Current price 42.5% below estimated low
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.29$, 3.71$]
- 2026-12-31 to 2027-12-31 estimated range: [1.02$, 2.94$]
Financial Metrics affecting the IVVD estimates:
- Positive: with PPE of -8.5 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of -0.04 > -0.60
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term IVVD quotes
Long-term IVVD plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $25.38MM | $53.43MM |
| Operating Expenses | $212.76MM | $202.26MM | $108.99MM |
| Operating Income | $-212.76MM | $-176.88MM | $-55.56MM |
| Non-Operating Income | $14.12MM | $6.95MM | $3.07MM |
| R&D Expense | $163.63MM | $137.25MM | $38.31MM |
| Income(Loss) | $-198.64MM | $-169.93MM | $-52.49MM |
| Net Income(Loss)* | $-198.64MM | $-169.93MM | $-52.49MM |
| Stockholders Equity | $177.47MM | $67.54MM | $241.54MM |
| Inventory | $0.00MM | $0.00MM | $25.50MM |
| Assets | $229.18MM | $129.51MM | $276.88MM |
| Operating Cash Flow | $-173.16MM | $-170.49MM | $-58.13MM |
| Capital expenditure | $0.61MM | $0.14MM | $0.15MM |
| Investing Cash Flow | $280.68MM | $-0.14MM | $-0.15MM |
| Financing Cash Flow | $1.04MM | $39.33MM | $215.63MM |
| Earnings Per Share** | $-1.81 | $-1.43 | $-0.30 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.